ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,778 | -36.2% | 28,952 | 0.0% | 0.01% | -37.5% |
Q2 2023 | $143,891 | +0.6% | 28,952 | 0.0% | 0.02% | 0.0% |
Q1 2023 | $143,023 | -21.5% | 28,952 | 0.0% | 0.02% | -20.0% |
Q4 2022 | $182,108 | -41.8% | 28,952 | 0.0% | 0.02% | -50.0% |
Q3 2022 | $313,000 | -5.2% | 28,952 | 0.0% | 0.04% | +2.6% |
Q2 2022 | $330,000 | +25.0% | 28,952 | 0.0% | 0.04% | +56.0% |
Q1 2022 | $264,000 | -72.4% | 28,952 | -54.8% | 0.02% | -77.7% |
Q4 2021 | $955,000 | +6.0% | 64,005 | +82.6% | 0.11% | +49.3% |
Q3 2021 | $901,000 | -11.4% | 35,053 | -10.1% | 0.08% | -6.2% |
Q2 2021 | $1,017,000 | -26.1% | 39,008 | 0.0% | 0.08% | -29.2% |
Q1 2021 | $1,377,000 | – | 39,008 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |